Contact
Please use this form to send email to PR contact of this press release:
CelerisTx in research collaboration with Merck KGaA, Darmstadt, Germany on AI-enabled degrader discovery
TO:
Christopher Trummer
Celeris Therapeutics
+43 660 3837648